Featuring Alex Kozinski, Judge, U.S. Court of Appeals for the Ninth Circuit; and J. Harvie Wilkinson III, Judge, U.S. Court of Appeals for the Fourth Circuit; moderated by Tim Lynch, Director, Project on Criminal Justice, Cato Institute.
So many Americans are concerned with how “Washington isn’t listening to them,” and candidates like Bernie Sanders, Donald Trump, and Ben Carson are stoking that outrage. But maybe Washington isn’t listening because it is so big that only mobilized special interests have the resources and incentives to pay attention. Maybe big government will never really pay attention to the people. If this is so, then maybe people should stop trying to control each other so much.
American leaders have cooperated with regimes around the world that are, to varying degrees, repressive or corrupt. Such cooperation is said to serve the national interest. But these partnerships also contravene the nation’s commitments to democratic governance, civil liberties, and free markets. In Perilous Partners, authors Ted Galen Carpenter and Malou Innocent provide a strategy for resolving the ethical dilemmas between interests and values faced by Washington.
The Cato Institute has released its 2014 Annual Report, which documents a dynamic year of growth and productivity. “Libertarianism is the philosophy of freedom,” Cato’s David Boaz writes in his book, The Libertarian Mind. “It is the indispensable framework for the future.” And as the new report demonstrates, the Cato Institute, thanks largely to the generosity of our Sponsors, is leading the charge to apply this framework across the policy spectrum.
Featuring Donald Abrams, M.D., Director of Clinical Programs, Osher Center for Integrative Medicine, University of California; Robert DuPont, M.D., President, Institute for Behavior and Health; Rob Kampia, Executive Director, Marijuana Policy Project; Moderated by Tim Lynch, Director, Project on Criminal Justice, Cato Institute
Ten years ago, on March 17, 1999, an important government study was released regarding certain patients’ use of marijuana as prescribed by their doctors. The Institute of Medicine, a branch of the National Academy of Sciences, issued what was then the most comprehensive analysis of the scientific and medical literature about marijuana. The report stated, “The accumulated data indicate a potential therapeutic value for cannabinoid drugs, particularly for symptoms such as pain relief, control of nausea and vomiting, and appetite stimulation.”Many medical experts continue to caution about harms that may result from smoking marijuana, though those harms need to be weighed against other harms that particular patients may be facing. In the political realm, the debate over the legal status of medical marijuana continues to rage. Since 1996, 12 states have legalized marijuana for medical use. What have medical scientists learned about marijuana over the past 10 years? And how have the politics on this contentious issue shifted at the federal and state level? Join us for a lively discussion of the science and politics of medical marijuana.